FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anton Scharl

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Anatomy

Co-author Network

Publications

TOP 3
Regine Gaetje; Anton Scharl; Manfred Kaufmann; Andre Ahr
[Management of abnormal uterine bleeding].
Anton Scharl; Serban-Dan Costa; N Duell; Uwe-Jochen Göhring; Regine Gaetje
[Suspicion for intraabdominal adhesions -- is open laparoscopy the gold standard?].
Serban-Dan Costa; Rainer Souchon; Anton Scharl
[Ipsilateral breast tumor recurrence after conservative breast cancer surgery -- diagnosis and therapy].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anton Scharl (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Regine Gaetje; Anton Scharl; Manfred Kaufmann; Andre Ahr
[Management of abnormal uterine bleeding].
Zentralblatt für Gynäkologie 2006;128(4):196-201.
2005: Anton Scharl; Serban-Dan Costa; N Duell; Uwe-Jochen Göhring; Regine Gaetje
[Suspicion for intraabdominal adhesions -- is open laparoscopy the gold standard?].
Zentralblatt für Gynäkologie 2005;127(6):380-4.
2004: Serban-Dan Costa; Rainer Souchon; Anton Scharl
[Ipsilateral breast tumor recurrence after conservative breast cancer surgery -- diagnosis and therapy].
Zentralblatt für Gynäkologie 2004;126(4):244-51.
2003: C Walter; Klemens Scheidhauer; Anton Scharl; U-J Goering; Peter Theissen; Harald Kugel; T Krahe; UE Pietrzyk
Clinical and diagnostic value of preoperative MR mammography and FDG-PET in suspicious breast lesions.
European radiology 2003;13(7):1651-6.
2002: E Heidemann; H Stoeger; Rainer Souchon; W-D Hirschmann; Heinrich Bodenstein; C Oberhoff; J Th Fischer; M Schulze; Michael Clemens; Reinhard Andreesen; M Mahlke; M König; Anton Scharl; K Fehnle; M Kaufmann
Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(11):1717-29.
2002: Christian M Kurbacher; Jutta A Kurbacher; Ian Cree; Eva Wardelmann; Ursula Stier; Hannelore Kolhagen; Anton Scharl; Peter E Andreotti
Chemosensitivity of normal human trophoblasts evaluated by a newly developed ATP-based luminescence assay.
Anti-cancer drugs 2002;13(7):701-8.
2002: Gunter von Minckwitz; Klaus Brunnert; Serban-Dan Costa; Kay Friedrichs; Christian Jackisch; Bernd Gerber; N Harbeck; H Junkermann; Volker Möbus; Ulrike Nitz; G Schaller; Anton Scharl; Ch Thomssen; M Untch
[Evidence-based recommendations on primary treatment of carcinomas of the breast].
Zentralblatt für Gynäkologie 2002;124(5):293-303.
2002: Gunter von Minckwitz; Serban-Dan Costa; Klaus Brunnert; P Dall; Ulrike Nitz; Ingo J Diel; N Fersis; Michael Friedrich; Kay Friedrichs; Ch Thomssen; Bernd Gerber; Uwe-Jochen Göhring; N Harbeck; V Hanf; G Schaller; Anton Scharl; Rita K Schmutzler; W E Simon; M Untch
[Evidence-based recommendations on treating locoregional and distant metastases of carcinomas of the breast].
Zentralblatt für Gynäkologie 2002;124(5):284-92.
2001: Andre Ahr; Uwe Holtrich; Christine Solbach; Anton Scharl; Klaus Strebhardt; Thomas Karn; Manfred Kaufmann
Molecular classification of breast cancer patients by gene expression profiling.
The Journal of pathology 2001;195(3):312-20.
2000: Manfred Kaufmann; Anton Scharl
Do we need better prognostic factors in nodal-negative breast cancer? Contra.
European journal of cancer (Oxford, England : 1990) 2000;36(3):298-301.
2000: Andre Ahr; Anton Scharl; K Lütke; S Staszewski; P Z Kacer; M Kaufmann
Cervical intraepithelial neoplasia in human immunodeficiency virus-positive patients.
Cancer detection and prevention 2000;24(2):179-85.
1999: Thomas Schöndorf; Anton Scharl; Christian M Kurbacher; O Bien; Martina Becker; Rainer Neumann; Hannelore Kolhagen; J Rustemeyer; Peter Mallmann; Uwe-Jochen Göhring
Amplification of the mdr1-gene is uncommon in recurrent ovarian carcinomas.
Cancer letters 1999;146(2):195-9.
1999: J Yuan; J Knorr; M Altmannsberger; G Goeckenjan; Andre Ahr; Anton Scharl; Klaus Strebhardt
Expression of p16 and lack of pRB in primary small cell lung cancer.
The Journal of pathology 1999;189(3):358-62.
1999: Andre Ahr; Anton Scharl; M Müller; Gunter von Minckwitz; R Gätje; K Pantel; Manfred Kaufmann
Cross-reactive staining of normal bone-marrow cells by monoclonal antibody 2E11.
International journal of cancer. Journal international du cancer 1999;84(5):502-5.
1999: Regine Gaetje; DW Winnekendonk; Anton Scharl; M Kaufmann
Ovarian cancer antigen CA 125 enhances the invasiveness of the endometriotic cell line EEC 145.
Journal of the Society for Gynecologic Investigation 1999;6(5):278-81.
1999: Thomas Schondorf; A Andrack; Dieter Niederacher; Anton Scharl; Martina Becker; Heike Engel; Uwe-Jochen Gohring
H-ras gene amplification or mutation is not common in human primary breast cancer.
Oncology reports 1999;6(5):1029-33.
1999: Uwe-Jochen Göhring; Thomas Schöndorf; V R Kiecker; Martina Becker; Christian M Kurbacher; Anton Scharl
Immunohistochemical detection of H-ras protooncoprotein p21 indicates favorable prognosis in node-negative breast cancer patients.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1999;20(4):173-83.
1998: Klaus Schomäcker; Th Fischer; B Böttcher; S A Mraheel; Anton Scharl; B Gabruk-Szostak; Klemens Scheidhauer; Uwe-Jochen Göhring; B Meller-Rehbein; S K Shukla; Harald Schicha
[Kinetics of receptor-mediated radiotoxicity of 16alpha-[125I]-iodostradiol-3,17beta].
Nuklearmedizin. Nuclear medicine 1998;37(4):134-40.
1998: Klemens Scheidhauer; Anton Scharl; Harald Schicha
Estrogen receptor scintigraphy.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1998;42(1):26-32.
1998: Thomas Schöndorf; Heike Engel; Christian M Kurbacher; U Brenne; Hannelore Kolhagen; Uwe-Jochen Göhring; Anton Scharl; Peter Mallmann
Immunologic features of tumor-infiltrating lymphocytes and peripheral blood lymphocytes in ovarian cancer patients.
Journal of the Society for Gynecologic Investigation 1998;5(2):102-7.
1997: Andre Ahr; G Arnold; Uwe-Jochen Göhring; Silvano Costa; Anton Scharl; J F Gauwerky
Cytology of ascitic fluid in a patient with metastasizing malignant Brenner tumor of the ovary. A case report.
Acta cytologica 1997;41(4 Suppl):1299-304.
1997: Klaus Schomäcker; H Hebrank; Klemens Scheidhauer; Anton Scharl; J C Saccavini; S K Shukla; Wolf-Gunter Franke; Harald Schicha
[Influence on extratumoral organ activities of tumor-affinity samarium-153 preparations].
Nuklearmedizin. Nuclear medicine 1997;36(2):47-51.
1997: Andre Ahr; Anton Scharl; Uwe-Jochen Göhring; Werner Neuhaus; Manfred Kaufmann
[Blind prophylactic antibiotic administration in premature rupture of fetal membranes].
Zentralblatt für Gynäkologie 1997;119(3):111-6.
1996: Anton Scharl; Klemens Scheidhauer; U Pietrzyk; Uwe-Jochen Göhring; Klaus Schomäcker
[Detection of multi-focal breast carcinoma using 2[18F] fluoro-deoxy-D-glucose positron emission tomography (FDG-PET)].
Geburtshilfe und Frauenheilkunde 1996;56(8):434-7.
1996: Klemens Scheidhauer; Anton Scharl; U Pietrzyk; R Wagner; Uwe-Jochen Göhring; Klaus Schomäcker; Harald Schicha
Qualitative [18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicability.
European journal of nuclear medicine 1996;23(6):618-23.
1996: Uwe-Jochen Göhring; Anton Scharl; Andre Ahr
[Value of immunohistochemical determination of receptors, tissue proteases, tumor suppressor proteins and proliferation markers as prognostic indicators in primary breast carcinoma].
Geburtshilfe und Frauenheilkunde 1996;56(4):177-83.
1996: Uwe-Jochen Göhring; Anton Scharl; U Thelen; Andre Ahr; G Crombach
Comparative prognostic value of Cathepsin D and urokinase plasminogen activator, detected by immunohistochemistry, in primary breast carcinoma.
Anticancer research 1996;16(2):1011-8.
1996: Anton Scharl; P Huber; J Lorenzen; Uwe-Jochen Göhring
Gastric cancer during early pregnancy. Two case reports.
Archives of gynecology and obstetrics 1996;258(3):151-4.
1996: Uwe-Jochen Göhring; Anton Scharl; U Thelen; Andre Ahr; G Crombach; B R Titius
Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods.
Journal of clinical pathology 1996;49(1):57-64.
1995: Uwe-Jochen Göhring; Anton Scharl; U Thelen; Andre Ahr; B R Titius
[Prognostic value of immunohistochemical determination of urokinase plasminogen activator in primary breast cancers].
Der Pathologe 1995;16(6):398-403.
1995: Han-Xiang An; Dieter Niederacher; Matthias W Beckmann; Uwe-Jochen Göhring; Anton Scharl; F Picard; C van Roeyen; HG Schnürch; Hans Georg Bender
ERBB2 gene amplification detected by fluorescent differential polymerase chain reaction in paraffin-embedded breast carcinoma tissues.
International journal of cancer. Journal international du cancer 1995;64(5):291-7.
1995: U Pietrzyk; Klemens Scheidhauer; Anton Scharl; A Schuster; Harald Schicha
Presurgical visualization of primary breast carcinoma with PET emission and transmission imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(10):1882-4.
1995: Klaus Schomäcker; B Hientzsch; Wolf-Gunter Franke; Klemens Scheidhauer; Anton Scharl; K Jantsch; Shyama Kant Shukla; Georgios Spyridon Limouris; Th Fischer; Harald Schicha
[Biokinetics of tumor-affinity yttrium preparations--2].
Nuklearmedizin. Nuclear medicine 1995;34(5):207-14.
1995: Uwe-Jochen Göhring; Andre Ahr; Anton Scharl; V Weisner; Werner Neuhaus; G Crombach; J A Holt
Immunohistochemical detection of epidermal growth factor receptor lacks prognostic significance for breast carcinoma.
Journal of the Society for Gynecologic Investigation 1995;2(4):653-9.
1995: Andre Ahr; Anton Scharl; Uwe-Jochen Göhring; G Crombach; M Stoffl
[Immunohistochemical detection of pS2 protein in paraffin sections of breast carcinoma tissue. Comparison with results of an immunoradiometry assay].
Der Pathologe 1995;16(4):278-84.
1995: B R Titius; Uwe-Jochen Göhring; Anton Scharl
[Bilateral breast carcinoma after recurrent myxoid liposarcoma of the breast].
Der Pathologe 1995;16(3):230-4.
1995: Matthias W Beckmann; Boris Tutschek; Uwe-Jochen Göhring; K Engels; F K Picard; Anton Scharl; Dieter Niederacher; HG Schnürch
[Immunohistochemical detection of epidermal growth factor receptor (EGF-R) in paraffin sections of breast carcinoma tissue: correlation and clinical significance].
Geburtshilfe und Frauenheilkunde 1995;55(5):258-65.
1995: Anton Scharl; Matthias W Beckmann; James E Artwohl; J A Holt
Comparisons of radioiodoestradiol blood-tissue exchange after intravenous or intraarterial injection.
International journal of radiation oncology, biology, physics 1995;32(1):137-46.
1995: K Schomäker; B Hientzsch; Wolf-Gunter Franke; Klemens Scheidhauer; Anton Scharl; K Jantsch; Shyama Kant Shukla; Georgios Spyridon Limouris; Harald Schicha
[Biokinetics of tumor-affinity yttrium preparations--Part 1].
Nuklearmedizin. Nuclear medicine 1995;34(1):32-9.
1995: Uwe-Jochen Göhring; Anton Scharl; C Heckel; Andre Ahr; G Crombach
P53 protein in 204 patients with primary breast carcinoma--immunohistochemical detection and clinical value as a prognostic factor.
Archives of gynecology and obstetrics 1995;256(3):139-46.
1994: G Crombach; A Ingenhorst; Uwe-Jochen Göhring; Anton Scharl; Hans-Jorg Schaeffer; Hartmut Stützer; A Bolte
[The prognostic significance of cathepsin D in primary breast cancer].
Geburtshilfe und Frauenheilkunde 1994;54(10):545-51.
1994: Peter Theissen; K Smolarz; Anton Scharl; A Groth; Klemens Scheidhauer; Eberhard Voth; Harald Schicha
[Magnetic resonance imaging in screening for bone metastasis? A prospective comparison with bone scintigraphy].
Nuklearmedizin. Nuclear medicine 1994;33(4):132-7.
1994: Werner Neuhaus; C Zok; Uwe-Jochen Göhring; Anton Scharl
A prospective study concerning psychological characteristics of patients with breast cancer.
Archives of gynecology and obstetrics 1994;255(4):201-9.
1993: Uwe-Jochen Göhring; A Ingenhorst; G Crombach; Anton Scharl
[Cathepsin D expression in primary breast cancer. Comparison of immunohistochemical and biochemical results].
Der Pathologe 1993;14(6):313-7.
1993: Uwe-Jochen Göhring; Y Aslan-Schadwinkel; Anton Scharl
[Expression of the p185neu oncoprotein indicates an unfavorable prognosis in small, node negative breast cancer without systemic adjuvant treatment (T1N0)].
Geburtshilfe und Frauenheilkunde 1993;53(9):625-9.
1993: Anton Scharl; J A Holt
Rapid vascular escape of arterially injected 16 alpha-radioiodo,17 beta-estradiol.
International journal of radiation oncology, biology, physics 1993;26(2):285-90.
1993: Matthias W Beckmann; Anton Scharl; B J Rosinsky; J A Holt
Breaks in DNA accompany estrogen-receptor-mediated cytotoxicity from 16 alpha[125I]iodo-17 beta-estradiol.
Journal of cancer research and clinical oncology 1993;119(4):207-14.
1993: G Crombach; A Ingenhorst; Uwe-Jochen Göhring; Anton Scharl; Werner Neuhaus; Volker Möbus; Hans-Jorg Schaeffer
Expression of pS2 protein in breast cancer.
Archives of gynecology and obstetrics 1993;253(4):183-92.
1992: J A Holt; Anton Scharl; S Kullander; Matthias W Beckmann
Intracellular actions of steroid hormones and their therapeutic value, including the potential of radiohalosteroids against ovarian cancer.
Acta obstetricia et gynecologica Scandinavica. Supplement 1992;155():39-54.
1992: Matthias W Beckmann; L J Toney; Anton Scharl; R Fuchs-Young; G L Greene; J A Holt
Detection of the HER-2/neu proto-oncogene protein p185erbB2 by a novel monoclonal antibody (MAB-145ww) in breast cancer membranes from oestrogen and progesterone receptor assays.
European journal of cancer (Oxford, England : 1990) 1992;28(2-3):322-6.
1991: Anton Scharl; S Kullander; Matthias W Beckmann; J A Spicer; R J Baranczuk; J A Holt
Prolonged clearance of intraperitoneal 16 alpha-[125I]iodo-17 beta-estradiol in presence of ascites.
American journal of obstetrics and gynecology 1991;165(6 Pt 1):1847-53.
1991: Anton Scharl; Matthias W Beckmann; James E Artwohl; S Kullander; J A Holt
Rapid liver metabolism, urinary and biliary excretion, and enterohepatic circulation of 16 alpha-radioiodo-17 beta-estradiol.
International journal of radiation oncology, biology, physics 1991;21(5):1235-40.
1991: Anton Scharl; G Crombach; Mathias Vierbuchen; Uwe-Jochen Göhring; T Göttert; J A Holt
Antigen CA 19-9: presence in mucosa of nondiseased müllerian duct derivatives and marker for differentiation in their carcinomas.
Obstetrics and gynecology 1991;77(4):580-5.
1990: Anton Scharl; Uwe-Jochen Göhring; Mathias Vierbuchen; B Küsters; H Würz
[Epidermal growth factor receptor (EGF-R) in human breast cancer--a marker of morphologic-functional differentiation].
Geburtshilfe und Frauenheilkunde 1990;50(11):877-82.
1990: Anton Scharl; M Günther; Uwe-Jochen Göhring; A Bolte; R Fischer
[Multifocal carcinoma of the upper female genital tract: diffuse Müllerian neoplasia].
Geburtshilfe und Frauenheilkunde 1990;50(2):158-60.
1990: Anton Scharl; Mathias Vierbuchen; B Conradt; W Moll; H Würz; A Bolte
Immunohistochemical detection of progesterone receptor in formalin-fixed and paraffin-embedded breast cancer tissue using a monoclonal antibody.
Archives of gynecology and obstetrics 1990;247(2):63-71.
1989: G Crombach; Anton Scharl; Mathias Vierbuchen; H Würz; A Bolte
Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinomas of the uterine cervix.
Cancer 1989;63(7):1337-42.
1989: G Crombach; Anton Scharl; H Würz
CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and Fallopian tube. II. Immunoradiometric determination in secretions, tissue extracts and serum.
Archives of gynecology and obstetrics 1989;244(2):113-22.
1989: Anton Scharl; G Crombach; Mathias Vierbuchen; H Müsch; A Bolte
CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and fallopian tube. I. Immunohistochemical detection.
Archives of gynecology and obstetrics 1989;244(2):103-12.
1989: Anton Scharl; Mathias Vierbuchen; H Würz
[Immunohistochemical detection of estrogen and progesterone receptors in breast cancer using monoclonal antibodies: comparison with biochemical receptor analysis].
Der Pathologe 1989;10(1):31-8.
1988: Anton Scharl; Mathias Vierbuchen; M Kusche; A Bolte
[Clinical aspects and prognosis of granulosa cell tumors of the ovary].
Geburtshilfe und Frauenheilkunde 1988;48(8):567-73.
1988: Anton Scharl; G Crombach; G Krueger; A Bolte
[Symptom of "urinary incontinence" as an indication of tubal cancer].
Geburtshilfe und Frauenheilkunde 1988;48(2):113-5.
1988: Anton Scharl; Mathias Vierbuchen; J Graupner; R Fischer; A Bolte
Immunohistochemical study of distribution of estrogen receptors in corpus and cervix uteri.
Archives of gynecology and obstetrics 1988;241(4):221-33.